Clinical Trials Browser

Completed × Nasopharyngeal Neoplasms × Nivolumab × Clear all

NCT02339558 2019-09-13

Nivolumab in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Cancer

Phase 2 Completed

45 enrolled 12 charts

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms